Fingerprint
Dive into the research topics of 'Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells
Peter P. Ruvolo, Vivian R. Ruvolo, Christopher B. Benton, Ahmed AlRawi, Jared K. Burks, Wendy Schober, James Rolke, George Tidmarsh, Numsen Hail, R. Eric Davis, Michael Andreeff
Research output: Contribution to journal › Article › peer-review
36
Scopus
citations